Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep;48(17):3323-3330.
doi: 10.1007/s00266-023-03832-y. Epub 2024 Jan 22.

The Problem of Diagnostic Criteria of Breast Implant Illness in Women After Breast Reconstruction: Review and Discussion of a Case

Anna Kasielska-Trojan  1 , Bogusław Antoszewski  2 , Marek Zadrożny  3 , Piotr Pluta  3
Affiliations
Review

The Problem of Diagnostic Criteria of Breast Implant Illness in Women After Breast Reconstruction: Review and Discussion of a Case

Anna Kasielska-Trojan et al. Aesthetic Plast Surg. 2024 Sep.

Abstract

Introduction: There has been a rising trend in the use of silicone breast implants for breast reconstructions after breast cancer treatment, as well as in the aesthetic breast procedures. A cluster of non-specific symptoms related to the presence of silicone implant has been called breast implant illness (BII). However, there are no strict criteria of BII which would specifically define this term. The increasing interest in BII among patients and physicians urges verifying own cases of "on-demand" explantations.

Material and methods: In this paper, we discussed a case of a patient with initial BII diagnosis, after breast reconstruction, and reviewed the literature on the BII symptoms and aetiology. A decision for aesthetic revision, not explantation, was made as the diagnosis of BII was questioned, and somatisation due to dissatisfaction with the aesthetic result of breast reconstruction was diagnosed.

Results: Improving aesthetics by implant exchange and contralateral mastopexy caused a full recovery from patient's symptoms.

Conclusion: Based on our case, we point on the fact that BII diagnosis in patients after breast reconstruction is challenging. We suggest that while considering such a diagnosis and further proceedings, e.g. explantation, especially in patients after breast reconstruction, some exclusion criteria should be considered. Dissatisfaction with the result of the surgery can also lead to somatisation and the presence of real clinical symptoms, which should not be confused with the possible autoimmune reaction to silicone particles.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Keywords: Breast implant illness; Diagnostic criteria; Explantation; Silicone implant; Symptoms.

PubMed Disclaimer

References

    1. Baldwin CM Jr, Kaplan EN (1983) Silicone-induced human adjuvant disease? Ann Plast Surg 10(4):270–273 - DOI - PubMed
    1. Watad A, Sharif K, Shoenfeld Y (2017) The ASIA syndrome: basic concepts. Mediterr J Rheumatol. 28(2):64–69 - DOI - PubMed - PMC
    1. Yang S, Klietz ML, Harren AK, Wei Q, Hirsch T, Aitzetmuller MM (2022) Understanding breast implant illness: etiology is the key. Aesthet Surg J 42(4):370–377 - DOI - PubMed
    1. U.S. Food & Drug Administration (2023) What to know about breast implants. https://www.fda.gov/consumers/consumer-updates/what-know-about-breast-im...
    1. Spit KA, Scharff M, de Blok CJ, Niessen FB, Bachour Y, Nanayakkara PW (2022) Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study. BMJ Open 12(6):e057159 - DOI - PubMed - PMC

LinkOut - more resources